Wells Fargo’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25K | Sell |
|
|||||
|
2025
Q1 | $29.5K | Buy |
|
|||||
|
2024
Q4 | $46.2K | Sell |
|
|||||
|
2024
Q3 | $120K | Buy |
|
|||||
|
2024
Q2 | $76.6K | Buy |
|
|||||
|
2024
Q1 | $74.4K | Buy |
|
|||||
|
2023
Q4 | $40.9K | Buy |
|
|||||
|
2023
Q3 | $23.1K | Sell |
|
|||||
|
2023
Q2 | $84.3K | Buy |
|
|||||
|
2023
Q1 | $37.3K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $2K | Sell |
|
|||||
|
2022
Q1 | $376K | Sell |
|
|||||
|
2021
Q4 | $1.94M | Sell |
|
|||||
|
2021
Q3 | $2.66M | Buy |
|
|||||
|
2021
Q2 | $1.35M | Buy |
|
|||||
|
2021
Q1 | $285K | Sell |
|
|||||
|
2020
Q4 | $197K | Sell |
|
|||||
|
2020
Q3 | $216K | Buy |
|
|||||
|
2020
Q2 | $217K | Buy |
|
|||||
|
2020
Q1 | $212K | Buy |
|
|||||
|
2019
Q4 | $298K | Buy |
|
|||||
|
2019
Q3 | $66K | Buy |
|
|||||
|
2019
Q2 | $131K | Sell |
|
|||||
|
2019
Q1 | $141K | Sell |
|
|||||
|
2018
Q4 | $169K | Sell |
|
|||||
|
2018
Q3 | $271K | Buy |
|
|||||
|
2018
Q2 | $301K | Sell |
|
|||||
|
2018
Q1 | $393K | Sell |
|
|||||
|
2017
Q4 | $535K | Sell |
|
|||||
|
2017
Q3 | $1.39M | Buy |
|
|||||
|
2017
Q2 | $1.46M | Sell |
|
|||||
|
2017
Q1 | $1.39M | Sell |
|
|||||
|
2016
Q4 | $1.53M | Sell |
|
|||||
|
2016
Q3 | $3.87M | Buy |
|
|||||
|
2016
Q2 | $1.05M | Sell |
|
|||||
|
2016
Q1 | $904K | Buy |
|
|||||
|
2015
Q4 | $212K | Sell |
|
|||||
|
2015
Q3 | $264K | Buy |
|
|||||
|
2015
Q2 | $122K | Buy |
|
|||||
|
2015
Q1 | $25K | Buy |
|
|||||
|
2014
Q4 | $14K | Buy |
|
|||||
|
2014
Q3 | $21K | Sell |
|
|||||
|
2014
Q2 | $35K | Buy |
|
|||||
|
2014
Q1 | $2K | Sell |
|
|||||
|
2013
Q4 | $3K | Sell |
|
|||||
|
2013
Q3 | $4K | Buy |
|
|||||
|
2013
Q2 | $3K | Buy |
|